Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
20–85
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Alzheimer´s Disease patients - 50-85 years- mild to moderate AD, clinical progression of AD over 12 months.
Healthy male volunteers: - Age 20-50 years, Body Mass Index: 18-30 kg/m2.
Clinically normal physical findings including normal blood pressure and pulse rate.
You may not be if
Alzheimer´s Disease patients:
significant cerebrovascular disease or depression, central nervous system infarct or infection or lesions
clinically significant illness within 2 weeks before the study start.
administration of any investigational product with effect on brain beta amyloid levels within 3 months prior to study and/or participation in a PET investigation other than study D0180C00011 as part of a scientific study during the past 12 months,.
Healthy volunteers; - clinically significant illness within 2 weeks before the study start, history of psychiatric or somatic disease/condition that may interfere.- first degree relative with dementia. Obvious deterioration of memory functions.
